Diagnostic Utility of Cardiac MRI for Patients with Abandoned or Epicardial Leads
This study is looking at how safe it is to perform a Cardiac MRI (CMR) in people who have abandoned (left in place but not used) or broken heart leads, or permanent leads placed on the outside of the heart (epicardial leads). Researchers will use Cardiac MRI to see if it's a safe and useful way to get diagnostic information in these patients. You might be able to join if you are 18 or older and have these types of heart leads. The main goal is to check the safety of the Cardiac MRI procedure over 6 months. The study status is currently unclear, and it plans to enroll 20 participants.
- Study design
- This is a prospective cohort study, meaning researchers will follow a group of participants over time. It is a descriptive case series, so it will not compare results to a control group.
- What's involved
- You will have a thorough check-up before the MRI, including a chest X-ray and device checks. You will be continuously monitored during the MRI and evaluated for any side effects afterward.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will evaluate the safety of the Cardiac MRI over 6 months after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Diagnostic Utility of Cardiac MRI
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluating the safety of CMR6 months
To systematically evaluate the safety of conducting cardiac Magnetic Resonance Imaging (MRI) in this high-risk patient group with abandoned, fractured endocardial leads or surgically implanted permanent epicardial leads, by monitoring clinical outcome and device functionality (if active device present). This is done by evaluating and reviewing the CMR images.